Cancer patients can respond very differently to the same treatment, while current testing may not reliably identify the therapy most likely to work for each tumor.
R&D Focus
Precision medicine company that provides exosome precision diagnostic product and services for neuro diseases
Innovative Solution
Zhongke Yiwei Technology is a precision medicine company that provides exosome precision diagnostic products and services for tumors and neurodegenerative diseases.
Investment Funding
Last Funding Stage
Angel
Total Funding Amount
1.37M
Last Funding Amount
1.37M
Last Funding Date
09-11-2023
Startup Stage
Seed
Lead Investors
CASVC
About
Zhongke Yiwei Technology is a precision medicine company that provides exosome precision diagnostic products and services for tumors and neurodegenerative diseases.
Something missing or incorrect on this page? Help us enrich this information
